IsPETase mutant with improved thermal stability and activity and application thereof

By mutation of the amino acid site of the IsPETase mutant TS-PETase, the IsPETase mutant with improved thermal stability and degradation activity was obtained, solving the problem of the existing low thermal stability of IsPETase restriction of biodegradation and achieving efficient degradation under the glass transition temperature conditions of PET plastics.

CN120082534APending Publication Date: 2025-06-03SUN YAT SEN UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202311645797.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-12-01
Publication Date
2025-06-03

AI Technical Summary

Technical Problem

The low thermal stability of existing IsPETases limits its application in the biodegradation of PET plastics, especially in the glass transition temperature range.

Method used

IsPETase mutants with improved thermal stability and degradation activity were obtained by performing single point mutation or combination mutations on specific amino acid sites of the IsPETase mutant TS-PETase.

Benefits of technology

It realizes efficient degradation of PET plastic under the glass transition temperature of PET plastic, while improving the thermal stability of enzymes and enhancing its application potential in the biodegradation process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120082534A_ABST
    Figure CN120082534A_ABST
Patent Text Reader

Abstract

The invention discloses an IsPETase mutant with improved thermal stability and activity and application of the IsPETase mutant. According to the invention, a mutant TS-PETase of PET plastic degrading enzyme IsPETase is taken as a parent, and the IsPETase mutant with improved thermal stability and / or PET degrading activity is obtained by performing single-point mutation or combined mutation on amino acid at a specific site of the mutant TS-PETase. The obtained IsPETase mutant can be used for effectively degrading PET (Polyethylene Terephthalate) plastics under a Tg condition, and can also be prepared into a corresponding preparation for degrading the PET plastics accumulated in the environment and improving the environment polluted by the PET plastics. The obtained IsPETase mutant can also be used for degrading PET-containing plastic products and assisting in harmless treatment of plastics. The IsPETase mutant with improved thermal stability and activity, provided by the invention, has a promoting effect on the development of industrial biodegradation of PET (Polyethylene Terephthalate) plastics.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of enzyme engineering. More specifically, it relates to an IsPETase mutant with improved thermal stability and activity and its application. Background Art

[0002] Polyethylene terephthalate (PET) is a widely used polyester plastic. Due to its poor degradability, it continuously accumulates in the environment, causing serious environmental pollution. With the continuous discovery of PET plastic-degrading enzymes, an economical and environmentally friendly biodegradation method has become an effective way to deal with PET plastic pollution.

[0003] The PET plastic-degrading enzyme (IsPETase) from the strain Ideonella sakaiensis 201-F6 has 5 to 120 times higher activity in degrading PET plastic at room temperature than other PET plastic-degrading enzymes, showing great application potential. However, the low thermal stability of IsPETase limits its application. When biodegradating PET plastic, the reaction is usually carried out at the glass transition temperature (Tg). At this temperature (65 - 75°C), PET plastic is in a molten state, and its rigid polymer chains show strong flexibility, which is conducive to the contact of PET plastic-degrading enzymes and the cleavage of ester bonds, achieving a better degradation effect. However, when biodegradating PET plastic, the reaction temperature is not the higher the better. When the temperature exceeds T g (65 - 75°C), it will accelerate the crystallization of PET plastic, hinder the contact between the enzyme and the polymer chain, and thus reduce the reaction rate. Therefore, obtaining a PET plastic-degrading enzyme that can degrade PET plastic at Tg conditions and has high activity is the key to achieving efficient biodegradation of PET plastic.

[0004] In recent years, researchers have obtained several IsPETase mutants with different degrees of improvement in activity and thermal stability through engineering modification of IsPETase. Among them, TS-PETase has the highest activity at 40 - 55°C, but when the temperature exceeds 60°C, the activity of this mutant will significantly decrease. Therefore, it is necessary to develop PET plastic-degrading enzyme mutants with better thermal stability to meet the needs of biodegradation of PET plastic. Although mutating the amino acids of PET plastic-degrading enzymes may improve their thermal stability, it is impossible to predict the impact of different mutations on the performance of PET plastic-degrading enzymes. To obtain a PET plastic-degrading enzyme that can degrade PET plastic at Tg conditions and has high activity, continuous exploration is still needed. Summary of the Invention

[0005] In view of the problems existing in the above-mentioned prior art, the present invention provides an IsPETase mutant with improved thermal stability and degradation activity, which can efficiently degrade PET plastics at g temperature.

[0006] The first object of the present invention is to provide a method for obtaining an IsPETase mutant with improved thermal stability and / or degradation activity.

[0007] The second object of the present invention is to provide an IsPETase mutant with improved thermal stability and / or degradation activity.

[0008] The third object of the present invention is to provide a gene encoding the IsPETase mutant.

[0009] The fourth object of the present invention is to provide a recombinant vector containing the gene.

[0010] The fifth object of the present invention is to provide a recombinant bacterium expressing the IsPETase mutant.

[0011] The sixth object of the present invention is to provide the application of the IsPETase mutant, the gene, the recombinant vector or the recombinant bacterium in degrading polyethylene terephthalate or plastic products containing polyethylene terephthalate.

[0012] The seventh object of the present invention is to provide the application of the IsPETase mutant, the gene, the recombinant vector or the recombinant bacterium in the preparation of products for degrading polyethylene terephthalate or plastic products containing polyethylene terephthalate.

[0013] The eighth object of the present invention is to provide a preparation for degrading polyethylene terephthalate or plastic products containing polyethylene terephthalate.

[0014] The above objects of the present invention are achieved by the following technical solutions:

[0015] Although the degradation activity of the PET plastic-degrading enzyme IsPETase at room temperature is higher than that of other PET plastic-degrading enzymes, the thermal stability of IsPETase is poor and cannot well meet the needs of biodegradation. The present invention uses the IsPETase mutant TS-PETase as the parent, and through single-site mutation or combined mutation of specific amino acid sites, an IsPETase mutant with improved thermal stability and / or degradation activity is obtained. Therefore, the present invention claims the IsPETase mutant with improved thermal stability and / or degradation activity and its application.

[0016] Specifically, the amino acid sequence of the mutant TS-PETase is shown in SEQ ID NO.1; the gene sequence is shown in SEQ ID NO.3.

[0017] The present invention provides a method for obtaining an IsPETase mutant with improved thermal stability and / or PET degradation activity. The method is as follows: mutating one or more of the amino acids at positions 66, 90, 130, 136, 137, 151, 152, 178, 185, 200, 202, 213, 250, and 261 in the amino acid sequence shown in SEQ ID NO.1; or mutating one or more of the amino acids at positions 59, 90, 106, 151, 156, 180, 185, and 191 in the amino acid sequence shown in SEQ ID NO.2.

[0018] Specifically, when mutating the amino acid sequence shown in SEQ ID NO.1, the method is as follows:

[0019] Mutating the lysine at position 66 to asparagine;

[0020] Or mutating the glutamine at position 90 to tyrosine;

[0021] Or replacing the tryptophan at position 130 with histidine;

[0022] Or replacing the glycine at position 136 with alanine;

[0023] Or replacing the serine at position 137 with threonine;

[0024] Or replacing the alanine at position 151 with isoleucine;

[0025] Or replacing the proline at position 152 with valine;

[0026] Or replacing the serine at position 178 with glutamate;

[0027] Or replacing the serine at position 185 with valine or histidine;

[0028] Or replacing the phenylalanine at position 200 with tyrosine;

[0029] Or replacing the glutamate at position 202 with methionine;

[0030] Or replacing the serine at position 213 with threonine;

[0031] Or replacing the threonine at position 250 with proline;

[0032] Or replacing the serine at position 261 with proline;

[0033] Or mutate lysine at position 66 to asparagine and replace serine at position 213 with threonine;

[0034] Or mutate glycine at position 136 to alanine and serine at position 137 to threonine;

[0035] Or mutate phenylalanine at position 200 to tyrosine and glutamate at position 202 to methionine;

[0036] Or replace threonine at position 250 with proline and serine at position 261 with proline;

[0037] Or replace glutamate at position 202 with methionine, threonine at position 250 with proline, and serine at position 261 with proline;

[0038] Or mutate lysine at position 66 to asparagine, replace glutamate at position 202 with methionine, replace serine at position 213 with threonine, replace threonine at position 250 with proline, and replace serine at position 261 with proline;

[0039] Or mutate lysine at position 66 to asparagine, replace glycine at position 136 with alanine, replace glutamate at position 202 with methionine, replace serine at position 213 with threonine, replace threonine at position 250 with proline, and replace serine at position 261 with proline;

[0040] Or mutate lysine at position 66 to asparagine, replace glycine at position 136 with alanine, replace serine at position 178 with glutamate, replace glutamate at position 202 with methionine, replace serine at position 213 with threonine, replace threonine at position 250 with proline, and replace serine at position 261 with proline.

[0041] Specifically, when mutating the amino acid sequence shown in SEQ ID NO.2, the method is as follows:

[0042] Replace threonine at position 59 with alanine or leucine;

[0043] Or mutate glutamine at position 90 to leucine;

[0044] Or replace alanine at position 151 with valine;

[0045] Or replace serine at position 185 with valine or phenylalanine;

[0046] Or replace aspartic acid at position 191 with glutamic acid or asparagine;

[0047] Or replace alanine at position 106 with cysteine and mutate threonine at position 122 to cysteine;

[0048] or mutate tryptophan at position 156 to cysteine and alanine at position 180 to cysteine;

[0049] or mutate glutamine at position 90 to leucine and replace aspartic acid at position 191 with glutamic acid;

[0050] or mutate glutamine at position 90 to leucine, replace alanine at position 106 with cysteine, and mutate threonine at position 122 to cysteine;

[0051] or replace alanine at position 106 with cysteine, mutate threonine at position 122 to cysteine, and replace aspartic acid at position 191 with glutamic acid;

[0052] or mutate glutamine at position 90 to leucine, replace alanine at position 106 with cysteine, mutate threonine at position 122 to cysteine, and replace aspartic acid at position 191 with glutamic acid;

[0053] or mutate glutamine at position 90 to leucine, replace alanine at position 106 with cysteine, mutate threonine at position 122 to cysteine, replace serine at position 185 with valine, and replace aspartic acid at position 191 with glutamic acid.

[0054] The present invention also provides an IsPETase mutant with improved thermal stability and / or activity, which is obtained by the above method.

[0055] Although the present invention does not give the amino acid or gene sequences of each mutant, based on the known amino acid and gene sequences of the parental TS-PETase, the amino acid and gene sequences of the corresponding mutant can be obtained by knowing the amino acids after mutation at the mutation sites. In addition to mutating the parent, the corresponding mutant can also be obtained by methods such as artificial synthesis according to the sequence of the mutant. Therefore, the present invention claims the gene encoding the IsPETase mutant. Using the gene, the corresponding IsPETase mutant can be obtained by recombinant expression.

[0056] The present invention also claims a recombinant vector for expressing the IsPETase mutant of the present invention.

[0057] Specifically, the recombinant vector contains the gene sequence encoding the IsPETase mutant of the present invention.

[0058] Optionally, the recombinant vector is an expression vector.

[0059] The present invention also claims a recombinant bacterium capable of expressing the IsPETase mutant of the present invention.

[0060] Specifically, the recombinant bacterium contains the recombinant vector of the present invention.

[0061] Optionally, when constructing the recombinant bacterium, Escherichia coli, yeast, Bacillus, Pseudomonas putida, etc. can be selected as the starting strain.

[0062] The present invention also claims the application of the IsPETase mutant, the gene, the recombinant vector or the recombinant bacterium in degrading plastics containing polyethylene terephthalate.

[0063] The present invention also claims the application of the IsPETase mutant, the gene, the recombinant vector or the recombinant bacterium in the preparation of products for degrading plastics containing polyethylene terephthalate.

[0064] The present invention also claims a preparation for degrading plastics containing polyethylene terephthalate, which contains the IsPETase mutant of the present invention or a recombinant bacterium capable of expressing the IsPETase mutant of the present invention.

[0065] The present invention has the following beneficial effects:

[0066] The present invention uses the mutant TS-PETase of the PET plastic degrading enzyme IsPETase as the parent, and obtains IsPETase mutants with improved thermal stability and / or PET degrading activity by performing single-site mutation or combined mutation on specific-site amino acids thereof. Using the obtained IsPETase mutants, PET plastics can be effectively degraded under T g conditions, and they can also be made into corresponding preparations for degrading PET plastics accumulated in the environment and improving the environment polluted by PET plastics. At the same time, the IsPETase mutants obtained in the present invention can also be used to degrade plastic products containing PET to assist in the harmless treatment of plastics. The IsPETase mutants with improved thermal stability and activity provided by the present invention promote the development of industrial biodegradation of PET plastics. Description of the Drawings

[0067] Figure 1 It is the plasmid map of the recombinant plasmid pET-28a(+)-TAC-M12.

[0068] Figure 2 It is the SDS-PAGE detection and grayscale analysis results of the solubility expression of TS-PETase and its mutants M16 and M17; A in the figure is the SDS-PAGE detection result; B in the figure is the grayscale analysis result of the solubility expression.

[0069] Figure 3 It is the determination result of the optimal temperature of the combined mutants M16 and M17.

[0070] Figure 4 The T values of mutant TS-PETase, combined mutants M16 and M17 m and their half-lives at 68-72°C; A in the figure is the measurement result of the T value of mutant TS-PETase, combined mutants M16 and M17 m ; B in the figure is the measurement result of the half-life of mutant TS-PETase, combined mutants M16 and M17, and mutant HotPETase at 68°C; C in the figure is the measurement result of the half-life of mutant TS-PETase, combined mutants M16 and M17, and mutant HotPETase at 70°C; D in the figure is the measurement result of the half-life of mutant TS-PETase, combined mutants M16 and M17, and mutant HotPETase at 72°C.

[0071] Figure 5 are the test results of the degradation activities of mutant TS-PETase, combined mutants M16 and M17, and mutant HotPETase. Detailed implementation manners

[0072] The present invention will be further described below in conjunction with the accompanying drawings of the specification and specific embodiments, but the embodiments do not impose any form of limitation on the present invention. Unless otherwise specified, the reagents, methods, and equipment used in the present invention are conventional reagents, methods, and equipment in the technical field.

[0073] Unless otherwise specified, the reagents and materials used in the following examples are all commercially available.

[0074] In the embodiment of the present invention, the amino acid sequence of mutant TS-PETase of PET plastic degrading enzyme IsPETase is shown in SEQ ID NO.1, and the gene sequence is shown in SEQ ID NO.3.

[0075] The formulations of the non-commercially available reagents used in the embodiments of the present invention are as follows:

[0076] LB liquid medium: yeast powder 5 g / L, tryptone 10 g / L, NaCl 10 g / L; based on the LB liquid medium, adding 20 g / L of agar gives LB solid medium.

[0077] 8×Binding buffer: NaCl 23.376 g, Tris base 1.9676 g, imidazole 0.2723 g, made up to 100 mL with ultrapure water, pH 7.9.

[0078] 8×Wash buffer: 23.376 g of NaCl, 1.9676 g of Tris base, 3.2678 g of imidazole, made up to 100 mL with ultrapure water, pH 7.9.

[0079] 4×Elute buffer: 11.668 g of NaCl, 0.96912 g of Tris base, 27.232 g of imidazole, made up to 100 mL with ultrapure water, pH 7.9.

[0080] 1×Binding buffer, 1×Wash buffer, and 1×Wash buffer are all diluted from their mother liquors.

[0081] The detection method involved in the embodiments of the present invention is as follows:

[0082] Drawing of the standard curve for terephthalic acid (TPA): Prepare a 5 mM mother liquor of TPA, and dilute it with buffer (50 mM Glycine-NaOH, pH 9.0) into TPA standard solutions of different concentrations; use the TPA standard solutions of different concentrations for HPLC analysis and read the peak areas; draw a standard curve with the concentration of the TPA standard solution as the abscissa and the peak area as the ordinate; the obtained formula is: y = 0.0499x + 0.3569, R2 = 0.9998.

[0083] Drawing of the standard curve for mono(2-hydroxyethyl) terephthalate (MHET): Prepare a 5 mM mother liquor of MHET, and dilute it with buffer (50 mM Glycine-NaOH, pH 9.0) into MHET standard solutions of different concentrations; use the MHET standard solutions of different concentrations for HPLC analysis and read the peak areas; draw a standard curve with the concentration of the MHET standard solution as the abscissa and the peak area as the ordinate; the obtained formula is: y = 0.0566x + 0.0099, R2 = 0.9999.

[0084] Half-life (t 1 / 2 ): "Half-life" is defined as the time corresponding to when the remaining activity of the PET plastic-degrading enzyme is 50% of the initial enzyme activity when incubated at a certain temperature.

[0085] Determination of half-life (t 1 / 2 ): Incubate the purified enzyme (the purified mutant) in a water bath at a certain temperature, and measure the remaining enzyme activity at different times.

[0086] Half-inactivation temperature (T 50 10 ): "Half-inactivation temperature" is defined as the temperature corresponding to when the PET plastic-degrading enzyme loses 50% of its initial activity within 10 min.

[0087] Half-inactivation temperature (T50 10 ) Determination: The purified enzyme was incubated at different temperatures for 10 min, and the remaining enzyme activity was measured.

[0088] Half-inactivation temperature change (ΔT 50 10 ): It represents the temperature difference between the mutant and the initial enzyme corresponding to a 50% loss of the initial activity within 10 min.

[0089] Determination of PET degradation activity: Purified enzyme was added to a buffer (50 mM Glycine-NaOH, pH 9.0) to make the final system volume 300 μL and the final concentration of the purified enzyme 200 nmol / L; 8 mg of PET plastic particles were added and mixed evenly; the mixture of the enzyme and the PET substrate was incubated at a specific temperature for 30 min. After the reaction, it was centrifuged at 14000 rpm for 1 min, the supernatant was taken, an equal volume of methanol was added, and after mixing, it was treated at 98 °C for 15 min to inactivate; it was centrifuged at 14000×g for 1 min, and the supernatant was filtered through a 0.22 μm filter, and the filtered sample was used for HPLC analysis; the degradation activity was expressed as the total concentration of PET degradation products, including the concentrations of TPA and MHET; the relative activity was the ratio of the total concentration of PET degradation products.

[0090] HPLC analysis method: The mobile phase used for separating the products was 0.1% (v / v) formic acid solution (phase A) and acetonitrile (phase B); the total flow rate was 0.8 mL / min, the detection wavelength was 260 nm, and the column temperature was 30 °C; separation method: The initial proportion of phase B was 1%, from 1 to 6 min, the proportion of phase B increased linearly from 1% to 5%, from 6 to 16 min, the proportion of phase B increased linearly from 5% to 70%, from 16 to 22 min, the proportion of phase B increased linearly from 70% to 100%, from 22 to 26 min, the proportion of phase B remained 100%, from 26 to 31 min, the proportion of phase B decreased linearly from 100% to 1%, and from 31 to 36 min, the proportion of phase B remained 1%.

[0091] Melting temperature (T m ) Determination: It was measured using a real-time fluorescence quantitative PCR instrument. First, 5 μg of the purified enzyme was mixed with 1×protein thermal shift dye, and the total volume was 20 μL; the program was set as Melt Curve, and it was heated from 25 °C to 99 °C at a rate of 1.6 °C / s; the curve was plotted by taking the derivative of the fluorescence intensity with respect to temperature to determine the T m value.

[0092] Example 1 Site-directed mutagenesis of mutant TS-PETase and analysis of the enzymatic properties of the obtained single-site mutants

[0093] The present invention uses the mutant TS-PETase of the PET plastic-degrading enzyme IsPETase as a parent, performs single-point mutations on specific amino acid sites thereof, and conducts thermal stability tests (i.e., measurement of the half-inactivation temperature (T 50 10 )) on the obtained single-point mutant mutants, and evaluates by calculating the change in the half-inactivation temperature (ΔT 50 10 ), and obtains 15 single-point mutants with ΔT 50 10 >1 °C. The relevant experimental procedures are as follows:

[0094] 1. Single-point mutation of the mutant TS-PETase

[0095] According to the codon preference of Escherichia coli, the gene sequence of the mutant TS-PETase of the PET plastic-degrading enzyme IsPETase was optimized and synthesized; the obtained optimized sequence (shown in SEQ ID NO.3) was ligated to the constructed pET-28a(+)-TAC vector to obtain the plasmid pET-28a(+)-TAC-IsPETase. The pET-28a(+)-TAC vector was obtained by inserting the TAC promoter into pET-28a(+).

[0096] Using the plasmid pET-28a(+)-TAC-IsPETase as a template, amino acid mutations were designed on the primers, and a long fragment of the IsPETase gene sequence containing the mutant amino acids was obtained by PCR amplification; the PCR reaction system is shown in Table 1:

[0097] Table 1 PCR reaction system

[0098]

[0099] The PCR reaction conditions were: the first stage: pre-denaturation at 98 °C for 3 min; the second stage: denaturation at 98 °C for 10 s, annealing at 55 °C for 5 s, extension at 72 °C for 1 min 30 s, for a total of 30 cycles; the third stage: extension at 72 °C for 3 min.

[0100] After the PCR amplification was completed, the PCR product was subjected to gel electrophoresis analysis, the gel recovery product was purified using the FastPure Gel DNA Extraction mini kit, and the recovered product was ligated to the pET-28a(+)-TAC vector using the Aike Rui seamless cloning ligation kit (OK Clon DNA). The ligation reaction system is shown in Table 2, and the reaction conditions were 50 °C for 15 min.

[0101] Table 2 Ligation reaction system

[0102]

[0103]

[0104] After the ligation reaction was completed, the ligation product was cooled on ice. 10 μL of the ligation product was taken and mixed with 100 μL of E. coli BL21(DE3) competent cells, and then heat-treated in a water bath at 42 °C for 1 min 30 s. The competent cells mixed with the ligation product were left standing on ice for 2 min, 900 μL of LB medium was added, and the mixture was cultured at 37 °C and 200 rpm for 1 h. The culture was evenly spread on an LB solid plate containing 50 μg / mL Kana and cultured overnight at 37 °C. Three morphologically normal single colonies were picked from the cultured plate and transferred to 20 mL of LB liquid medium, and cultured overnight at 37 °C and 220 rpm. The overnight cultured bacterial solution was sent to Guangzhou Ruibo Biotechnology Company for sequencing to obtain the DNA sequence of the ligation product, and the corresponding bacterial solution was stored for subsequent experiments.

[0105] 2. Purification of the single-point mutant and determination of its enzymatic properties

[0106] The E. coli BL21(DE3) strain containing the single-point mutation after sequencing was cultured overnight at 37 °C and 220 rpm to obtain sufficient bacterial cells. The overnight culture was transferred to a new LB liquid medium at a volume ratio of 3:100 with LB liquid medium (containing 50 μg / mL Kana), and cultured with shaking at 37 °C and 220 rpm until the OD600 nm of the bacterial solution reached 0.8 - 1.0. IPTG (final concentration 0.6 mM) was added to induce protein expression, and the culture was continued at 16 °C and 180 rpm for 24 h. The cells were collected by centrifugation at 10,000×g for 10 min, broken, and the crude enzyme solution was obtained. The crude enzyme solution was purified to obtain the single-point mutant protein (purified enzyme).

[0107] The purification steps of the crude enzyme solution are as follows:

[0108] (1) The collected bacterial cells were resuspended in 10 mL of 1×Binding Buffer, and the cells were broken using an ultrasonic cell disruptor. After the disruption was completed, the supernatant was collected by centrifugation (10,000×g, 8 min), and the supernatant was filtered through a 0.45 μm filter membrane to obtain the crude enzyme solution;

[0109] (2) 4 mL of His Bin resin was taken and added to the filter column to form a purification column;

[0110] (3) The purification column was washed successively with 10 mL of ultrapure water and 10 mL of 1×Binding Buffer;

[0111] (4) Slowly add the crude enzyme solution into the purification column;

[0112] (5) Add 20 mL of 1× Binding Buffer and 12 mL of 1× Wash Buffer, then elute with 5 mL of 1× Elute Buffer and collect the protein eluate;

[0113] (6) The eluted protein was replaced with potassium phosphate buffer (pH 7.0, 50 mM) using a 10 kDa ultrafiltration tube and stored at 4°C.

[0114] The half-inactivation temperature change (ΔT 50 10 ) and its PET degradation activity relative to TS-PETase at 55°C for 30 min. The results obtained were 15 ΔT 50 10 The results of determination of the single point mutants with thermal stability>1°C and the enzymatic properties of the 15 single point mutants with beneficial thermal stability mutations are shown in Table 3.

[0115] Table 3 ΔT on TS-PETase 50 10 >1℃15 single point mutants and their activities

[0116]

[0117] Note: K66N means mutation of lysine at position 66 to asparagine; the rest are analogous; the activities mentioned in the table are percentages of activity with TS-PETase.

[0118] As shown in Table 3, the activities of single point mutants TS-K66N, TS-S178E, TS-S213T, TS-G136A, TS-E202M, TS-T250P, TS-S261P, TS-S137T and TS-F200Y relative to TS-PETase are more than 80%. Among them, the activities of single point mutants TS-K66N, TS-S178E and TS-S213T are respectively increased by 32%, 22% and 19% compared with TS-PETase, that is, while the thermal stability is improved, the PET degradation activity is also improved.

[0119] Example 2 Combination mutation of mutant TS-PETase and analysis of enzymatic properties of the resulting combined mutants

[0120] On the basis of Example 1, the present invention obtained four ΔT values ​​by combining and superimposing different single-point mutations and measuring the half-inactivation temperature changes of the resulting mutants. 50 10Mutants with a temperature increase of >2℃ are TS-G136A / S137T, TS-E202M / F200Y, TS-T250P / S261P, and TS-K66N / S213T; the method for obtaining these mutants is the same as in Example 1. On this basis, by sequentially stacking the mutations and measuring the change in the semi-inactivation temperature of the resulting mutants, the present invention obtained 4 ΔT 50 10 combinatorial mutants with a temperature increase of >6℃, named M8, M10, M11, and M12, respectively.

[0121] The above-obtained double mutant mutants and combinatorial mutants were purified respectively, and using TS-PETase as a control, their PET degradation activities relative to TS-PETase were measured at 55℃ for 30 min. The results are shown in Table 4.

[0122] Table 4 Test results of the thermal stability and activity of the combinatorial mutations of mutant TS-PETase

[0123]

[0124] Specifically, TS-K66N-S213T is obtained by mutating lysine at position 66 of mutant TS-PETase to asparagine and substituting serine at position 213 with threonine;

[0125] TS-G136A-S137T is obtained by mutating glycine at position 136 of mutant TS-PETase to alanine and serine at position 137 to threonine;

[0126] TS-E202M-F200Y is obtained by mutating phenylalanine at position 200 of mutant TS-PETase to tyrosine and glutamate at position 202 to methionine;

[0127] TS-T250P-S261P is obtained by substituting threonine at position 250 of mutant TS-PETase with proline and serine at position 261 with proline;

[0128] M8 is obtained by substituting glutamate at position 202 of mutant TS-PETase with methionine, threonine at position 250 with proline, and serine at position 261 with proline;

[0129] M10 is obtained by mutating lysine at position 66 of mutant TS-PETase to asparagine, substituting glutamate at position 202 with methionine, serine at position 213 with threonine, threonine at position 250 with proline, and serine at position 261 with proline;

[0130] M11 is a mutant in which lysine at position 66 of mutant TS-PETase is mutated to asparagine, glycine at position 136 is replaced by alanine, glutamate at position 202 is replaced by methionine, serine at position 213 is replaced by threonine, threonine at position 250 is replaced by proline, and serine at position 261 is replaced by proline;

[0131] M12 is a mutant in which lysine at position 66 of mutant TS-PETase is mutated to asparagine, glycine at position 136 is replaced by alanine, serine at position 178 is replaced by glutamate, glutamate at position 202 is replaced by methionine, serine at position 213 is replaced by threonine, threonine at position 250 is replaced by proline, and serine at position 261 is replaced by proline.

[0132] As can be seen from Table 4, the T of mutant M12 50 10 is 77.71 °C, the semi-inactivation temperature is increased by 12.4 °C compared with the parental TS-PETase, and the PET degradation activity is increased by 16% compared with the parental TS-PETase. Subsequently, based on mutant M12, its thermal stability was further optimized.

[0133] Example 3 Optimization of the thermal stability of mutant M12

[0134] Using the gene sequence of the obtained mutant M12 (shown in SEQ ID NO.4) as a template, through the strategies of designing disulfide bonds and constructing a random mutation library, beneficial mutations with further improved thermal stability were obtained relative to mutant M12.

[0135] 1. Design of disulfide bonds

[0136] The mutant M12 was predicted for disulfide bonds using the disulfide bond design tools MODIP and DBD to search for disulfide bonds with the effect of improving thermal stability, and two beneficial mutants for thermal stability, M12-A106C / T122C and M12-W156C / A180C, were obtained, with T 50 10 increased by 1.70 °C and 3.46 °C respectively.

[0137] 2. Random mutation

[0138] (1) Construction of recombinant plasmid pET-28a(+)-TAC-M12

[0139] The recombinant plasmid pET-28a(+)-TAC-M12 was obtained by amplifying or synthesizing the gene sequence of mutant M12 and ligating it into the pET-28a(+)-TAC vector. The plasmid map of the recombinant plasmid is as Figure 1As shown in the figure. The obtained recombinant plasmid pET-28a(+)-TAC-M12 was transferred into Escherichia coli DH5α competent cells according to the method described in Example 1 for subsequent experiments.

[0140] (2) Double-layer plate screening

[0141] IsPETase can hydrolyze tributyrin, thus showing a clear zone on the plate containing tributyrin emulsion and rhodamine B staining solution. The DH5α strain containing the recombinant plasmid pET-28a(+)-TAC-M12 was spread on an LB solid medium containing 10 μM IPTG and 50 μg / mL Kana, and the colonies were cultured at 30 °C for 36 h; the cultured solid plates were respectively treated at high temperatures of 65 °C and 75 °C for 40, 50, and 60 min; after the medium cooled down, 10 mL of the upper layer clear zone medium was poured in, and the reaction was continued for 1 h at 45 °C, and the clear zone situation of the colonies was observed; the treatment temperature and time without a clear zone were selected as the conditions for screening mutants with improved thermal stability.

[0142] The preparation method of the upper layer clear zone plate is as follows:

[0143] 1 g of agar powder was added to 100 mL of deionized water, dissolved by boiling in a microwave oven, then 500 μL of tributyrin emulsion and 1 mL of rhodamine B staining solution were added, and mixed well.

[0144] (3) Construction and screening of a random mutation library

[0145] Using the recombinant plasmid pET-28a(+)-TAC-M12 as a template, the gene sequence of the PET-degrading enzyme mutant M12 was randomly mutated using error-prone PCR technology.

[0146] The sequences (5’-3’) of the primers used in error-prone PCR are as follows:

[0147] M12-BamHⅠ-F: TTTTGTTTAACTTTAAGAAGGAGATATACATATGGGATCC

[0148] M12-Xhol I-R: ATCTCAGTGGTGGTGGTGGTGGTGCTCGAG

[0149] The error-prone PCR reaction system is shown in Table 5:

[0150] Table 5 Error-prone PCR reaction system

[0151]

[0152] The error-prone PCR reaction conditions are as follows: pre-denaturation at 98°C for 3 min; denaturation at 98°C for 10 s, annealing at 55°C for 5 s, extension at 72°C for 2 min 30 s (the extension rate of this enzyme is 1 min / Kb), for a total of 30 cycles; then extension at 72°C for 10 min. Gel electrophoresis analysis was performed on the PCR products to determine the target gene band, and the target band was recovered from the gel.

[0153] The plasmid pET-28a and the error-prone PCR products were double-digested with the restriction endonucleases BamHⅠ and Xhol I respectively, and the reaction was carried out at 37°C for 2 h. The double-digestion systems of plasmid pET-28a and error-prone PCR products are shown in Table 6:

[0154] Table 6 Double-digestion systems of plasmid pET-28a and error-prone PCR products

[0155]

[0156] After the digestion reaction was completed, the digestion products were purified using the FastPure Gel DNA Extraction Mini Kit. The error-prone PCR products and the vector pET-28a were mixed at a molar ratio of 3:1 and ligated at 22°C for 1 h. The ligation system is shown in Table 7:

[0157] Table 7 Ligation system

[0158]

[0159] After the ligation reaction ended, the ligation products were purified using a purification kit and eluted with 30 μL of sterile water, and the eluted ligation products were quantified; 5 μL (150 ng) of the ligation products were fully mixed with 100 μL of E.coli DH5α electrocompetent cells (E.coli DH5α Electro-Cells, purchased from Takara), added to a pre-cooled 0.1 cm electroporation cuvette, and the cells were electroporated with a voltage of 1500 V, and 900 μL of SOC medium (E.coli DH5α Electro-Cells, purchased from Takara) was quickly added; the transformants were cultured at 37°C and 200 rpm for 1 h; the cultured transformants were evenly spread on LB solid medium supplemented with 10 μM IPTG and 50 μg / mL Kana, and cultured at 30°C for 36 h to obtain a random mutation library of the target gene.

[0160] The randomly mutated library incubated at 30 °C for 36 h was treated at 75 °C for 60 min; after the plate cooled down, 10 mL of upper layer transparent halo medium was poured in and the halo was developed continuously at 45 °C for 1 h; single colonies showing transparent halos (i.e., positive clones) were picked, resuspended with Solution I of HiPure Plasmid Micro Kit, and the plasmids in the colonies were extracted; the extracted plasmids were transformed into E. coli BL21(DE3) strain, and the transformation products were spread on LB solid medium (containing 50 μg / mL Kana) and cultured overnight at 37 °C.

[0161] Single colonies were picked into LB liquid medium containing 50 μg / mL kana and cultured overnight at 37 °C and 220 rpm. 3% of the bacterial solution was transferred to 20 mL of LB medium and cultured at 37 °C and 200 rpm until the OD 600 of the bacteria was 0.8 - 1.0. 0.12 mL of inducer IPTG (final concentration 0.6 mM) was added, and the culture was continued at 16 °C and 180 rpm for 20 h. The bacteria were collected by centrifugation (5000 g, 10 min, 4 °C). After adding an equal volume of 50 mM sodium hydrogen phosphate buffer at pH 7.0 to resuspend the bacteria sufficiently, an ultrasonic disruptor was used to break the cell wall. After centrifugation at 14000 rpm for 1 min, the supernatant was collected to obtain the crude enzyme solution.

[0162] The semi-inactivation temperature (T 50 10 ) of the above crude enzyme solution was detected; using the PET-degrading enzyme mutant M12 as a control, the positive mutations with improved T 50 10 were sequenced to determine the mutation sites and mutant sequences.

[0163] 3. Determination of the thermal stability and activity of mutants

[0164] Based on mutant M12, the present invention obtained 10 beneficial mutants with improved thermal stability by designing disulfide bonds and constructing a randomly mutated library, namely M12-T59A, M12-T59L, M12-Q90L, M12-A151V, M12-S185V, M12-S185F, M12-D191E, M12-D191N, M12-A106C-T122C, M12-W156C-A180C. The results of the thermal stability and activity determination of the above beneficial mutants are shown in Table 8.

[0165] Table 8 Analysis of the thermal stability and activity of beneficial mutations

[0166]

[0167] Example 4 Enzymatic property analysis of combined mutants

[0168] In the random mutation library constructed in Example 3, the present invention also obtained 5 combinatorial mutants with improved thermal stability, named M14, M15-1, M15-2, M16 and M17 in sequence.

[0169] Specifically, in M14, the glutamine at the 90th position of the M12 sequence was replaced with leucine, and the aspartic acid at the 191st position was replaced with glutamic acid.

[0170] In M15-1, the glutamine at the 90th position of the M12 sequence was replaced with leucine, the alanine at the 106th position was replaced with cysteine, and the threonine at the 122nd position was replaced with cysteine;

[0171] In M15-2, the alanine at the 106th position of the M12 sequence was replaced with cysteine, the threonine at the 122nd position was replaced with cysteine, and the aspartic acid at the 191st position was replaced with glutamic acid;

[0172] In M16, the glutamine at the 90th position of the M12 sequence was replaced with leucine, the alanine at the 106th position was replaced with cysteine, the threonine at the 122nd position was replaced with cysteine, and the aspartic acid at the 191st position was replaced with glutamic acid;

[0173] In M17, the glutamine at the 90th position of the M12 sequence was replaced with leucine, the alanine at the 106th position was replaced with cysteine, the threonine at the 122nd position was replaced with cysteine, the serine at the 185th position was replaced with valine, and the aspartic acid at the 191st position was replaced with glutamic acid.

[0174] The combinatorial mutants M8, M10, M11, M12, M14, M15-1, M15-2, M16 and M17 were purified respectively to obtain purified enzymes, and the thermal stability, PET degradation activity and relative activity of the obtained purified enzymes were measured. The results are shown in Table 9.

[0175] Table 9 T of purified enzymes of TS-PETase and its combinatorial mutants 50 10 and PET degradation activity

[0176]

[0177]

[0178] Note: "Concentration of PET degradation products" is the sum of the total concentration of PET degradation products, including the concentrations of TPA and MHET.

[0179] As can be seen from Table 8, among the combinatorial mutants obtained by the present invention, the thermal stabilities of mutants M16 and M17 are the most prominent. Among them, the T of mutant M16 50 10was 81.85 °C, 16.18 °C higher than that of the wild type. The T of mutant M17 50 10 was 85.42 °C, 19.75 °C higher than that of the wild type. Therefore, mutants M16 and M17 were selected for further analysis in the following steps.

[0180] Example 5 Verification of Enzymatic Properties of Mutants M16 and M17

[0181] 1. Induced Expression of Mutants

[0182] Take the bacterial suspensions of the expression strains of mutant TS-PETase, mutants M16 and M17, and streak them on LB solid medium containing 1 mg kanamycin (kana) respectively. After culturing at 37 °C for 24 h, pick single colonies and inoculate them into LB liquid medium containing 50 mg / mL kana, and culture them on a shaker at 37 °C and 220 rpm for 14 h; Take 3% of the bacterial suspension and transfer it to 100 mL LB medium, and culture it at 37 °C and 200 rpm until the OD600 of the bacteria is 0.8 - 1.0. Then add 0.6 mL of inducer IPTG (final concentration is 0.6 mM), and continue to culture at 16 °C and 180 rpm for 20 h; Measure the density of the induced bacteria, centrifuge at 4 °C and 5000 g for 10 min to collect the bacteria; Add an equal volume of 50 mM sodium hydrogen phosphate buffer at pH 7.0 to the bacteria to fully resuspend the bacteria, break the cell wall using an ultrasonic disruptor, and after centrifuging at 14000 rpm for 1 min, collect the supernatant to obtain the crude enzyme solution.

[0183] Perform SDS-PAGE detection on the obtained crude enzyme solution and calculate the gray value of the electrophoresis band to evaluate the soluble expression levels of recombinant mutants TS-PETase, M16 and M17. The results are as Figure 2 shown, Figure 2 A in Figure 2 is the SDS-PAGE analysis result, Figure 2 and B in

[0184] is the gray value of the electrophoresis band. As can be seen from

[0185] The mutant HotPETase is a PET-degrading enzyme with good reported thermal stability, and its sequence was obtained with reference to the literature. The literature is: Bell E L, Smithson R, Kilbride S. Directed evolution of an efficient and thermostable PET depolymerase[J]. Nature Catalysis, 2022(8):5.. The literature link is: https: / / doi.org / 10.1038 / s41929-022-00821-3.

[0186] 2. Enzymatic property analysis of mutants M16 and M17

[0187] In the present invention, the crude enzyme solutions containing TS-PETase, mutants M16 and M17, and mutant HotPETase obtained above were purified according to the method described in Example 1, and the enzymatic properties of the purified proteins of TS-PETase, mutants M16 and M17, and mutant HotPETase were analyzed, including the determination of the optimal temperature, melting temperature (T m ), and half-life.

[0188] Optimal temperature determination: After mixing the purified protein with the substrate PET in a buffer solution (50 mM Glycine-NaOH, pH 9.0), the catalytic reaction was carried out at 65-75 °C; other conditions remained unchanged except for the reaction temperature. The results of the optimal temperature determination of M16 and M17 are as Figure 3 shown. It can be seen from Figure 3 that the optimal temperatures of the combined mutants M16 and M17 are 68 °C and 70 °C, respectively.

[0189] The T m values and half-life determination results of the PET plastic-degrading enzyme IsPETase mutants TS-PETase, mutants M16 and M17 are as Figure 4 shown, Figure 4 where A in Figure 4 is the Tm value determination result of TS-PETase and mutants M16 and M17; B is the 68 °C half-life determination result of TS-PETase, mutants M16 and M17, and the currently reported mutant HotPETase with the best thermal stability; C is the 70 °C half-life determination result of TS-PETase, mutants M16 and M17, and HotPETase; D is the 72 °C half-life determination result of TS-PETase, mutants M16 and M17, and HotPETase. It can be seen from Figure 4 that the T mThe value is 86.02 °C, 14.01 °C higher than that of TS-PETase. The T of mutant M17 m value is 89.23 °C, 17.22 °C higher than that of TS-PETase. For reference, the T of mutant HotPETase m value is 82.5 °C (https: / / doi.org / 10.1038 / s41929-022-00821-3), and the T of mutants M16 and M17 m values are also higher than that of mutant HotPETase. In addition, the half-lives of mutant M16 at 68, 70, and 72 °C are approximately 35 h, 32 h, and 12 h respectively; the half-lives of mutant M17 at 68, 70, and 72 °C are approximately 62 h, 54 h, and 30 h respectively, which are 350 - 1080 times that of TS-PETase.

[0190] Example 6 Determination of PET degradation ability of mutants M16 and M17

[0191] Using PET plastic as the substrate, the degradation products TPA and MHET in the system were detected by high performance liquid chromatography (HPLC) to reflect the PET degradation ability of the mutants. In the present invention, the IsPETase mutant TS-PETase, mutants M16 and M17, and mutant HotPETase were used as targets, and the PET degradation abilities of these four enzymes were determined.

[0192] The specific method is as follows:

[0193] The purified enzymes of TS-PETase, M16, and M17 obtained were respectively added to a buffer (200 mM Glycine-NaOH, pH 9.5) to make the final system 20 mL, the substrate concentration was 26.7 g / L, and the final concentration of the purified enzyme was 1000 nM. After mixing evenly, the reactions were carried out at their respective optimal temperatures of 55 °C, 68 °C, 70 °C and a rotation speed of 250 rpm. Using the same method as in Example 5, HotPETase was heterologously expressed and purified. The purified enzyme of HotPETase obtained was added to a buffer with a pH of 9.2, and the reaction was carried out at its optimal temperature of 65 °C and a rotation speed of 250 rpm. The other conditions were the same as those of the above purified enzymes. The content of the reaction products was detected by HPLC to determine the PET degradation ability of the above purified enzymes, and the results are as Figure 5 shown.

[0194] From Figure 5It can be seen that after reacting with PET for 0.5 h, 1 h, 2 h, 3 h and 4 h, the amount of products generated by the mutant M16 degrading PET is the highest, which is 1.49 - 2.32 times that of TS-PETase and 1.20 - 1.74 times that of HotPETase. The amount of products of the mutant M17 is the second, which is 1.37 - 1.61 times that of TS-PETase and 1.04 - 1.37 times that of HotPETase. The specific data are shown in Table 10. The above results indicate that the mutants M16 and M17 can efficiently degrade PET at temperatures above 65°C and have good application potential in the industrial biodegradation of PET.

[0195] Table 10 PET degradation capabilities of TS-PETase and its mutants M16 and M17

[0196]

[0197] Note: The "concentration of PET degradation products" is the sum of the total concentrations of PET degradation products, including the concentrations of TPA and MHET.

[0198] The above embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications made without departing from the spirit and principle of the present invention shall be equivalent replacement methods and are all included in the protection scope of the present invention.

Claims

1. A method for obtaining an IsPETase mutant with improved thermal stability and / or degradation activity, characterized in that, the method is: mutating one or more of the amino acids at positions 66, 90, 130, 136, 137, 151, 152, 178, 185, 200, 202, 213, 250, 261 of the amino acid sequence shown in SEQ ID NO.1; or mutating one or more of the amino acids at positions 59, 90, 106, 122, 151, 156, 180, 185, 191 of the amino acid sequence shown in SEQ ID NO.

2.

2. The method according to claim 1, characterized in that, when mutating the amino acid sequence shown in SEQ ID NO.1, mutating the lysine at position 66 to asparagine; or mutating the glutamine at position 90 to tyrosine; or replacing the tryptophan at position 130 with histidine; or replacing the glycine at position 136 with alanine; or replacing the serine at position 137 with threonine; or replacing the alanine at position 151 with isoleucine; or replacing the proline at position 152 with valine; or replacing the serine at position 178 with glutamate; or replacing the serine at position 185 with valine or histidine; or replacing the phenylalanine at position 200 with tyrosine; or replacing the glutamate at position 202 with methionine; or replacing the serine at position 213 with threonine; or replacing the threonine at position 250 with proline; or replacing the serine at position 261 with proline; or mutating the lysine at position 66 to asparagine and replacing the serine at position 213 with threonine; or mutating the glycine at position 136 to alanine and mutating the serine at position 137 to threonine; or mutating the phenylalanine at position 200 to tyrosine and mutating the glutamate at position 202 to methionine; or replacing the threonine at position 250 with proline and replacing the serine at position 261 with proline; or replacing the glutamate at position 202 with methionine, replacing the threonine at position 250 with proline, and replacing the serine at position 261 with proline; or mutating the lysine at position 66 to asparagine, replacing the glutamate at position 202 with methionine, replacing the serine at position 213 with threonine, replacing the threonine at position 250 with proline, and replacing the serine at position 261 with proline; or mutating the lysine at position 66 to asparagine, replacing the glycine at position 136 with alanine, replacing the glutamate at position 202 with methionine, replacing the serine at position 213 with threonine, replacing the threonine at position 250 with proline, and replacing the serine at position 261 with proline; or mutating the lysine at position 66 to asparagine, replacing the glycine at position 136 with alanine, replacing the serine at position 178 with glutamate, replacing the glutamate at position 202 with methionine, replacing the serine at position 213 with threonine, replacing the threonine at position 250 with proline, and replacing the serine at position 261 with proline.

3. The method according to claim 1, characterized in that, When mutating the amino acid sequence shown in SEQ ID NO.2, threonine at position 59 is replaced with alanine or leucine; or glutamine at position 90 is mutated to leucine; or alanine at position 151 is replaced with valine; or serine at position 185 is replaced with valine or phenylalanine; or aspartic acid at position 191 is replaced with glutamic acid or asparagine; or alanine at position 106 is replaced with cysteine, and threonine at position 122 is mutated to cysteine; or tryptophan at position 156 is mutated to cysteine, and alanine at position 180 is mutated to cysteine; or glutamine at position 90 is mutated to leucine, and aspartic acid at position 191 is replaced with glutamic acid; or glutamine at position 90 is mutated to leucine, alanine at position 106 is replaced with cysteine, and threonine at position 122 is mutated to cysteine; or alanine at position 106 is replaced with cysteine, threonine at position 122 is mutated to cysteine, and aspartic acid at position 191 is replaced with glutamic acid; or glutamine at position 90 is mutated to leucine, alanine at position 106 is replaced with cysteine, threonine at position 122 is mutated to cysteine, and aspartic acid at position 191 is replaced with glutamic acid; or glutamine at position 90 is mutated to leucine, alanine at position 106 is replaced with cysteine, threonine at position 122 is mutated to cysteine, serine at position 185 is replaced with valine, and aspartic acid at position 191 is replaced with glutamic acid.

4. An IsPETase mutant with improved thermal stability and / or degradation activity, characterized in that the mutant is obtained by the method according to any one of claims 1 to 3.

5. A gene encoding the IsPETase mutant according to claim 4.

6. A recombinant vector, characterized in that it contains the gene according to claim 5.

7. A recombinant bacterium, characterized in that it expresses the IsPETase mutant according to claim 4.

8. Use of the IsPETase mutant according to claim 4, the gene according to claim 5, the recombinant vector according to claim 6 or the recombinant bacterium according to claim 7 in degrading polyethylene terephthalate or plastic products containing polyethylene terephthalate.

9. Use of the IsPETase mutant according to claim 4, the gene according to claim 5, the recombinant vector according to claim 6 or the recombinant bacterium according to claim 7 in preparing a product for degrading polyethylene terephthalate or plastic products containing polyethylene terephthalate.

10. A preparation for degrading polyethylene terephthalate or plastic products containing polyethylene terephthalate, characterized in that it contains the IsPETase mutant according to claim 4 or the recombinant bacterium according to claim 7.

Citation Information

Cited By

  • IsPETase mutant and application of IsPETase mutant in degradation of PET plastic

    CN122146652A